Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.05 CHF | -1.76% |
|
-3.70% | +10.62% |
06-20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
06-20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.62% | 525M | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Transcript : Basilea Pharmaceutica AG, 2021 Earnings Call, Feb 15, 2022